Toxic Leukoencephalopathies

Neurologic Clinics

Volumn 29, Issue 3, 2011, Pages 591-605

  Tormoehlen, Laura M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

" Chasing the dragon"; Carbon monoxide; Delayed neurologic sequelae; Heroin; Post anoxic; Posterior reversible encephalopathy syndrome

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BEVACIZUMAB; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DIAMORPHINE; DOXORUBICIN; ETOPOSIDE; FINGOLIMOD; GEMCITABINE; IMMUNOGLOBULIN; INTERFERON; METHOTREXATE; RAPAMYCIN; RITUXIMAB; SORAFENIB; SUNITINIB; TACROLIMUS; UBIQUINONE; VINCRISTINE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AKATHISIA; AKINETIC MUTISM; APATHY; ATAXIA; CARBON MONOXIDE INTOXICATION; COMPUTER ASSISTED TOMOGRAPHY; DELAYED POSTHYPOXIC LEUKOCENCEPHALOPATHY; DIFFUSION WEIGHTED IMAGING; ENCEPHALITIS; GAIT DISORDER; GAS POISONING; HEADACHE; HEART ARREST; HUMAN; HYPERPYREXIA; INHALATION; LEUKODYSTROPHY; LEUKOENCEPHALOPATHY; MAGNETIC RESONANCE ANGIOGRAPHY; MENTAL HEALTH; MULTIPLE SCLEROSIS; MYOCLONUS; NAUSEA; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RESPIRATION DEPRESSION; REVIEW; SHOCK; SPASTIC PARESIS; SPEECH DISORDER; STRANGULATION; TOXIC LEUKOENCEPHALOPATHY; VISUAL IMPAIRMENT; WHITE MATTER;

CARBON MONOXIDE; CARBON MONOXIDE POISONING; HEROIN; HUMANS; LEUKOENCEPHALOPATHIES;

EID: 79960795837     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.05.005     Document Type: Review

References (117)

1. Choi I.S. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983, 40:433-435.
2. Lee H.B., Lyketsos C.G. Delayed post-hypoxic leukoencephalopathy. Psychosomatics 2001, 42:530-533.
3. Custodio C.M., Basford J.R. Delayed postanoxic encephalopathy: a case report and literature review. Arch Phys Med Rehabil 2004, 85:502-505.
4. Plum F., Posner J.B., Hain R.F. Delayed neurological deterioration after anoxia. Arch Intern Med 1962, 110:18-25.
5. Hori A., Hirose G., Kataoka S., et al. Delayed postanoxic encephalopathy after strangulation. Serial neuroradiological and neurochemical studies. Arch Neurol 1991, 48:871-874.
6. Mizutani T., Shiozawa R., Takemori S., et al. Delayed post-anoxic encephalopathy without relation to carbon monoxide poisoning. Intern Med 1993, 32:430-433.
7. Weinberger L.M., Schmidley J.W., Schafer I.A., et al. Delayed postanoxic demyelination and arylsulfatase-A pseudodeficiency. Neurology 1994, 44:152-154.
8. Protass L.M. Delayed postanoxic encephalopathy after heroin use. Ann Intern Med 1971, 74:738-739.
9. Barnett M.H., Miller L.A., Reddel S.W., et al. Reversible delayed leukoencephalopathy following intravenous heroin overdose. J Clin Neurosci 2001, 8:165-167.
10. Shprecher D., Mehta L. The syndrome of delayed post-hypoxic leukoencephalopathy. NeuroRehabilitation 2010, 26:65-72.
11. Lee M.S., Marsden C.D. Neurological sequelae following carbon monoxide poisoning clinical course and outcome according to the clinical types and brain computed tomography scan findings. Mov Disord 1994, 9:550-558.
12. Chen-Plotkin A.S., Pau K.T., Schmahmann J.D. Delayed leukoencephalopathy after hypoxic-ischemic injury. Arch Neurol 2008, 65:144-145.
13. Gottfried J.A., Mayer S.A., Shungu D.C., et al. Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology 1997, 49:1400-1404.
14. Posner J.B., Saper C.B., Schiff N.D., et al. Plum and Posner's diagnosis of stupor and coma 2007, Oxford University Press, New York, p. 210-1. 4th edition.
15. Heckmann J.G., Erbguth F., Neundörfer B. Delayed postanoxic demyelination registry. Neurology 1998, 51:1235-1236.
16. Shprecher D.R., Flanigan K.M., Smith A.G., et al. Clinical and diagnostic features of delayed hypoxic leukoencephalopathy. J Neuropsychiatry Clin Neurosci 2008, 20:473-477.
17. Khot S., Walker M., Lacy J.M., et al. An unsuccessful trial of immunomodulatory therapy in delayed posthypoxic demyelination. Neurocrit Care 2007, 7:253-256.
18. Molloy S., Soh C., Williams T.L. Reversible delayed posthypoxic leukoencephalopathy. AJNR Am J Neuroradiol 2006, 27:1763-1765.
19. Min S.K. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr Scand 1986, 73:80-86.
20. Kawada N., Ochiai N., Kuzuhara S. Diffusion MRI in acute carbon monoxide poisoning. Intern Med 2004, 43:639-640.
21. Singhal A.B., Topcuoglu M.A., Koroshetz W.J. Diffusion MRI in three types of anoxic encephalopathy. J Neurol Sci 2002, 196:37-40.
22. Choi I.S., Lee M.S., Lee Y.J., et al. Technetium-99m HM-PAO SPECT in patients with delayed neurologic sequelae after carbon monoxide poisoning. J Korean Med Sci 1992, 7:11-18.
23. Choi I.S., Kim S.K., Lee S.S., et al. Evaluation of outcome of delayed neurologic sequelae after carbon monoxide poisoning by technetium-99m hexamethylpropylene amine oxime brain single photon emission computed tomography. Eur Neurol 1995, 35:137-142.
24. Norkool D.M., Kirkpatrick J.N. Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 1985, 14:1168-1171.
25. Myers R.A. Carbon monoxide poisoning. J Emerg Med 1984, 1:245-248.
26. Kao L.W., Nañagas K.A. Carbon monoxide poisoning. Emerg Med Clin North Am 2004, 22:985-1018.
27. Thom S.R., Bhopale V.M., Han S.T., et al. Intravascular neutrophil activation due to carbon monoxide poisoning. Am J Respir Crit Care Med 2006, 174:1239-1248.
28. Raphael J.C., Elkharrat D., Jars-Guincestre M.C., et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989, 2:414-419.
29. Ducassé J.L., Celsis P., Marc-Vergnes J.P. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation?. Undersea Hyperb Med 1995, 22:9-15.
30. Thom S.R., Taber R.L., Mendiguren I.I., et al. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995, 25:474-480.
31. Mathieu D., Wattel F., Mathieu-Nolf M., et al. Randomized prospective study comparing the effect of HBO versus 12 hours NBO in non-comatose CO poisoned patients: results of interim analysis. Undersea Hyperb Med 1996, 23:7-8. [abstract].
32. Scheinkestel C.D., Bailey M., Myles P.S., et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust 1999, 170:203-210.
33. Weaver L.K., Hopkins R.O., Chan K.J., et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002, 347:1057-1067.
34. Annane D., Chadda K., Gajdos P., et al. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med 2011, 37:486-492.
35. Hampson N.B., Mathieu D., Piantadosi C.A., et al. Carbon monoxide poisoning: interpretation of randomized clinical trials and unresolved treatment issues. Undersea Hyperb Med 2001, 28:157-164.
36. Strang J., Griffiths P., Gossop M. Heroin smoking by 'chasing the dragon': origins and history. Addiction 1997, 92:673-683. [discussion: 685-95].
37. Hendriks V.M., van den Brink W., Blanken P., et al. Heroin self-administration by means of 'chasing the dragon': pharmacodynamics and bioavailability of inhaled heroin. Eur Neuropsychopharmacol 2001, 11:241-252.
38. Wolters E.C., van Wijngaarden G.K., Stam F.C., et al. Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 1982, 2:1233-1237.
39. Offiah C., Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin Radiol 2008, 63:146-152.
40. Long H., Deore K., Hoffman R.S., et al. A fatal case of spongiform leukoencephalopathy linked to "chasing the dragon" J Toxicol Clin Toxicol 2003, 41:887-891.
41. Kriegstein A.R., Shungu D.C., Millar W.S., et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (" chasing the dragon"). Neurology 1999, 53:1765-1773.
42. Buxton J.A., Sebastian R., Clearsky L., et al. Chasing the dragon- Characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia. Harm Reduct J 2011, 8:3.
43. Weber W., Henkes H., Möller P., et al. Toxic spongiform leucoencephalopathy after inhaling heroin vapour. Eur Radiol 1998, 8:749-755.
44. Kriegstein A.R., Armitage B.A., Kim P.Y. Heroin inhalation and progressive spongiform leukoencephalopathy. N Engl J Med 1997, 336:589-590.
45. Gupta P.K., Krishnan P.R., Sudhakar P.J. Hippocampal involvement due to heroin inhalation-" chasing the dragon" Clin Neurol Neurosurg 2009, 111:278-281.
46. Tan T.P., Algra P.R., Valk J., et al. Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings. AJNR Am J Neuroradiol 1994, 15:175-178.
47. Celius E.G., Andersson S. Leucoencephalopathy after inhalation of heroin: a case report. J Neurol Neurosurg Psychiatry 1996, 60:694-695.
48. Gacouin A., Lavoue S., Signouret T., et al. Reversible spongiform leucoencephalopathy after inhalation of heated heroin. Intensive Care Med 2003, 29:1012-1015.
49. Keogh C.F., Andrews G.T., Spacey S.D., et al. Neuroimaging features of heroin inhalation toxicity: "chasing the dragon" AJR Am J Roentgenol 2003, 180:847-850.
50. Hagel J., Andrews G., Vertinsky T., et al. "Chasing the dragon" -imaging of heroin inhalation leukoencephalopathy. Can Assoc Radiol J 2005, 56:199-203.
51. Bartlett E., Mikulis D.J. Chasing "chasing the dragon" with MRI: leukoencephalopathy in drug abuse. Br J Radiol 2005, 78:997-1004.
52. Au-Yeung K., Lai C. Toxic leucoencephalopathy after heroin inhalation. Australas Radiol 2002, 46:306-308.
53. Ryan A., Molloy F.M., Farrell M.A., et al. Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J Neurol Neurosurg Psychiatry 2005, 76:1014-1016.
54. Chen C.Y., Lee K.W., Lee C.C., et al. Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. J Comput Assist Tomogr 2000, 24:735-737.
55. Maschke M., Fehlings T., Kastrup O., et al. Toxic leukoencephalopathy after intravenous consumption of heroin and cocaine with unexpected clinical recovery. J Neurol 1999, 246:850-851.
56. Chang W.C., Lo C.P., Kao H.W., et al. MRI features of spongiform leukoencephalopathy following heroin inhalation. Neurology 2006, 67:504.
57. Brenneisen R., Hasler F. GC/MS determination of pyrolysis products from diacetylmorphine and adulterants of street heroin samples. J Forensic Sci 2002, 47:885-888.
58. Sempere A.P., Posada I., Ramo C., et al. Spongiform leucoencephalopathy after inhaling heroin. Lancet 1991, 338:320.
59. Büttner A., Mall G., Penning R., et al. The neuropathology of heroin abuse. Forensic Sci Int 2000, 113:435-442.
60. Halloran O., Ifthikharuddin S., Samkoff L. Leukoencephalopathy from "chasing the dragon" Neurology 2005, 64:1755.
61. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494-500.
62. Bartynski W.S. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008, 29:1036-1042.
63. Mukherjee P., McKinstry R.C. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001, 219:756-765.
64. Glusker P., Recht L., Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006, 354:980-982. [discussion: 980-2].
65. Incecik F., Hergüner M.O., Altunbasak S., et al. Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurol India 2009, 57:475-478.
66. Dicuonzo F., Salvati A., Palma M., et al. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. J Child Neurol 2009, 24:1013-1018.
67. Mavragani C.P., Vlachoyiannopoulos P.G., Kosmas N., et al. A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion. Rheumatology 2004, 43:1450-1451.
68. Moskowitz A., Nolan C., Lis E., et al. Posterior reversible encephalopathy syndrome due to sirolimus. Bone Marrow Transplant 2007, 39:653-654.
69. Govindarajan R., Adusumilli J., Baxter D.L., et al. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol 2006, 24:e48.
70. Cumurciuc R., Martinez-Almoyna L., Henry C., et al. Posterior reversible encephalopathy syndrome during sunitinib therapy. Rev Neurol (Paris) 2008, 164:605-607.
71. Kappos L., Antel J., Comi G., et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006, 355:1124-1140.
72. Koichihara R., Hamano S.I., Yamashita S., et al. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome. Pediatr Neurol 2008, 39:123-125.
73. Belmouaz S., Desport E., Leroy F., et al. Posterior reversible encephalopathy induced by intravenous immunoglobulin. Nephrol Dial Transplant 2008, 23:417-419.
74. De Klippel N., Sennesael J., Lamote J., et al. Cyclosporin leukoencephalopathy induced by intravenous lipid solution. Lancet 1992, 339:1114.
75. Wu Q., Marescaux C., Wolff V., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation. Eur Neurol 2010, 64:169-177.
76. Bodkin C.L., Eidelman B.H. Sirolimus-induced posterior reversible encephalopathy. Neurology 2007, 68:2039-2040.
77. Ito Y., Arahata Y., Goto Y., et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998, 19:415-417.
78. Hemmaway C., Mian A., Nagy Z. Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy. Br J Haematol 2010, 150:129.
79. Russell M.T., Nassif A.S., Cacayorin E.D., et al. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 2001, 19:129-132.
80. Tam C.S., Galanos J., Seymour J.F., et al. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004, 77:72-76.
81. Reece D.E., Frei-Lahr D.A., Shepherd J.D., et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991, 8:393-401.
82. Vaughn D.J., Jarvik J.G., Hackney D., et al. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993, 14:1014-1016.
83. Bartynski W.S., Zeigler Z., Spearman M.P., et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001, 22:1901-1914.
84. Mahoney D.H., Shuster J.J., Nitschke R., et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-a Pediatric Oncology Group study. J Clin Oncol 1998, 16:1712-1722.
85. Asato R., Akiyama Y., Ito M., et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992, 70:1997-2004.
86. Bartynski W.S., Tan H.P., Boardman J.F., et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008, 29:924-930.
87. Wong R., Beguelin G.Z., de Lima M., et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003, 122:128-134.
88. Noè A., Cappelli B., Biffi A., et al. High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr 2010, 36:14.
89. Duncan R., Hadley D., Bone I., et al. Blindness in eclampsia: CT and MR imaging. J Neurol Neurosurg Psychiatry 1989, 52:899-902.
90. Schwartz R.B., Jones K.M., Kalina P., et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992, 159:379-383.
91. McKinney A.M., Short J., Truwit C.L., et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007, 189:904-912.
92. Donmez F.Y., Basaran C., Kayahan Ulu E.M., et al. MRI features of posterior reversible encephalopathy syndrome in 33 patients. J Neuroimaging 2010, 20:22-28.
93. Finocchi V., Bozzao A., Bonamini M., et al. Magnetic resonance imaging in posterior reversible encephalopathy syndrome: report of three cases and review of literature. Arch Gynecol Obstet 2005, 271:79-85.
94. Casey S.O., Sampaio R.C., Michel E., et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000, 21:1199-1206.
95. Ay H., Buonanno F.S., Schaefer P.W., et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998, 51:1369-1376.
96. Henderson R.D., Rajah T., Nicol A.J., et al. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003, 60:326-328.
97. Thaipisuttikul I., Phanthumchinda K. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005, 252:230-231.
98. Sweany J.M., Bartynski W.S., Boardman J.F. "Recurrent" posterior reversible encephalopathy syndrome: report of 3 cases-PRES can strike twice!. J Comput Assist Tomogr 2007, 31:148-156.
99. Bartynski W.S., Boardman J.F. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008, 29:447-455.
100. Ito T., Sakai T., Inagawa S., et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995, 16:1344-1346.
101. Lin J.T., Wang S.J., Fuh J.L., et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003, 24:102-104.
102. Ito Y., Niwa H., Iida T., et al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997, 49:1174-1175.
103. Trommer B.L., Homer D., Mikhael M.A. Cerebral vasospasm and eclampsia. Stroke 1988, 19:326-329.
104. Bartynski W.S., Sanghvi A. Neuroimaging of delayed eclampsia. Report of 3 cases and review of the literature. J Comput Assist Tomogr 2003, 27:699-713.
105. Aeby A., David P., Fricx C., et al. Posterior reversible encephalopathy syndrome revealing acute post-streptococcal glomerulonephritis. J Child Neurol 2006, 21:250-251.
106. Geraghty J.J., Hoch D.B., Robert M.E., et al. Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology 1991, 41:1145-1147.
107. Apollon K.M., Robinson J.N., Schwartz R.B., et al. Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet Gynecol 2000, 95:1017-1019.
108. Sanchez-Carpintero R., Narbona J., López de Mesa R., et al. Transient posterior encephalopathy induced by chemotherapy in children. Pediatr Neurol 2001, 24:145-148.
109. Naidu K., Moodley J., Corr P., et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997, 104:1165-1172.
110. Edvinsson L., Owman C., Sjöberg N.O. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976, 115:377-393.
111. Beausang-Linder M., Bill A. Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand 1981, 111:193-199.
112. Bartynski W.S. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008, 29:1043-1049.
113. Lanzino G., Cloft H., Hemstreet M.K., et al. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg 1997, 99:222-226.
114. Thyagarajan G.K., Cobanoglu A., Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997, 64(14):61-64.
115. Schiff D., Lopes M.B. Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2005, 2:303-305.
116. Greenwood M.J., Dodds A.J., Garricik R., et al. Posterior leukoencephalopathy in association with the tumour lysis syndrome in acute lymphoblastic leukaemia-a case with clinicopathological correlation. Leuk Lymphoma 2003, 44:719-721.
117. Cain M.S., Burton G.V., Holcombe R.F. Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids. Am J Med Sci 1998, 315:202-207.